SLNB in cutaneous SCC: A review of the current state of literature and the direction for the future.
The concept of the sentinel lymph node biopsy (SLNB) has been universally accepted for melanoma, however, remains controversial for squamous cell carcinoma (SCC). We performed a quantitative review on 260 cases of SCC that had a SLNB. The positivity rate was found to be 14.6%. Literature was qualitatively reviewed to determine whether a positive SLNB has any bearing on prognosis in SCC cases, finding a significant relationship between poor prognosis and a positive SLN (P = 0.0082).
['Ahadiat|Omeed|O|http://orcid.org/0000-0002-1036-2991', 'Higgins|Shauna|S|', 'Sutton|Adam|A|', 'Ly|Alexandre|A|', 'Wysong|Ashley|A|']
D002294:Carcinoma, Squamous Cell D006801:Humans D011237:Predictive Value of Tests D021701:Sentinel Lymph Node Biopsy D012878:Skin Neoplasms
SLNB SCC high-risk